|
1
|
Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality.
|
BJU Int
|
2008
|
2.60
|
|
2
|
Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients.
|
Am J Hum Genet
|
2010
|
1.67
|
|
3
|
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.
|
Am J Pathol
|
2012
|
1.48
|
|
4
|
Different types of atrophy in the prostate with and without adenocarcinoma.
|
Eur Urol
|
2006
|
1.48
|
|
5
|
Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.
|
Clin Cancer Res
|
2004
|
1.46
|
|
6
|
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer.
|
J Mol Med (Berl)
|
2012
|
1.23
|
|
7
|
Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours.
|
J Steroid Biochem Mol Biol
|
2006
|
1.19
|
|
8
|
Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosis.
|
Prostate
|
2005
|
1.12
|
|
9
|
The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.
|
Prostate
|
2010
|
1.10
|
|
10
|
Long-term follow up of renal anastomosing hemangioma mimicking renal angiosarcoma.
|
Int J Urol
|
2014
|
1.09
|
|
11
|
Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less.
|
J Urol
|
2010
|
1.07
|
|
12
|
Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway.
|
Carcinogenesis
|
2012
|
1.06
|
|
13
|
Real-time sonoelastography for the evaluation of testicular lesions.
|
Radiology
|
2012
|
1.05
|
|
14
|
The expression of transcription factor activating transcription factor 3 in the human prostate and its regulation by androgen in prostate cancer.
|
J Urol
|
2006
|
1.05
|
|
15
|
Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer.
|
Mol Cancer
|
2009
|
1.02
|
|
16
|
PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21.
|
Am J Pathol
|
2012
|
1.02
|
|
17
|
Proteomics profiling of microdissected low- and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker.
|
J Proteome Res
|
2010
|
1.00
|
|
18
|
Development of a multiplexed urine assay for prostate cancer diagnosis.
|
Clin Chem
|
2008
|
0.99
|
|
19
|
Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008.
|
Int J Public Health
|
2011
|
0.96
|
|
20
|
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.96
|
|
21
|
Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor.
|
Cancer Gene Ther
|
2002
|
0.95
|
|
22
|
A new rule-based algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry.
|
Bioinformatics
|
2008
|
0.93
|
|
23
|
High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.
|
Mod Pathol
|
2012
|
0.93
|
|
24
|
Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation.
|
Endocrinology
|
2013
|
0.91
|
|
25
|
Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection.
|
Breast Cancer Res Treat
|
2010
|
0.91
|
|
26
|
STAT1 activation in squamous cell cancer of the oral cavity: a potential predictive marker of response to adjuvant chemotherapy.
|
Cancer
|
2007
|
0.90
|
|
27
|
SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.
|
Endocr Relat Cancer
|
2014
|
0.89
|
|
28
|
Comparison of real-time sonoelastography with T2-weighted endorectal magnetic resonance imaging for prostate cancer detection.
|
J Ultrasound Med
|
2011
|
0.89
|
|
29
|
Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.
|
PLoS One
|
2013
|
0.88
|
|
30
|
Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.
|
BMC Cancer
|
2013
|
0.88
|
|
31
|
Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF-β treatment.
|
Am J Pathol
|
2011
|
0.87
|
|
32
|
Assessment of aberrations on chromosome 8 in prostatic atrophy.
|
BJU Int
|
2006
|
0.85
|
|
33
|
Value of enhanced transrectal ultrasound targeted biopsy for prostate cancer diagnosis: a retrospective data analysis.
|
World J Urol
|
2011
|
0.84
|
|
34
|
Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.
|
Int J Cancer
|
2010
|
0.84
|
|
35
|
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
|
Urol Int
|
2015
|
0.84
|
|
36
|
Comparison of real-time elastography and multiparametric MRI for prostate cancer detection: a whole-mount step-section analysis.
|
AJR Am J Roentgenol
|
2014
|
0.84
|
|
37
|
Adverse pathological findings in needle biopsy gleason score 6 prostate cancers with low and intermediate preoperative PSA levels following radical prostatectomy.
|
Anticancer Res
|
2012
|
0.81
|
|
38
|
Potentials and limitations of real-time elastography for prostate cancer detection: a whole-mount step section analysis.
|
ScientificWorldJournal
|
2012
|
0.80
|
|
39
|
IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9.
|
Endocr Relat Cancer
|
2013
|
0.79
|
|
40
|
Immunohistochemical tracking of an immune response in mammary Paget's disease.
|
Cancer Lett
|
2008
|
0.79
|
|
41
|
Therapy-resistant metastasizing anaplastic spermatocytic seminoma: a cytogenetic hybrid: a case report.
|
Anal Quant Cytopathol Histpathol
|
2014
|
0.78
|
|
42
|
Gain of chromosome X in prostatic atrophy detected by CGH and FISH analyses.
|
Prostate
|
2007
|
0.77
|
|
43
|
Treatment of severe bilateral nerve pain after Pfannenstiel incision.
|
Urology
|
2006
|
0.76
|
|
44
|
Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivo.
|
Int J Mol Sci
|
2013
|
0.75
|
|
45
|
Prognostic significance of 14-3-3sigma expression in oral squamous cell carcinoma (OSCC).
|
Oral Oncol
|
2008
|
0.75
|
|
46
|
Clinically insignificant improvement of prostate cancer prediction by addition of sex steroid hormones and SHBG serum levels to serum PSA, fPSA%, and age in a screening setting.
|
Horm Mol Biol Clin Investig
|
2012
|
0.75
|
|
47
|
De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound.
|
Urol Int
|
2014
|
0.75
|
|
48
|
Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraine.
|
Urol Int
|
2013
|
0.75
|
|
49
|
Galactocele in a young male patient.
|
Plast Reconstr Surg
|
2003
|
0.75
|